- Home
- SABS vs NDLS Comparison
SABS vs NDLS Comparison
Compare SABS & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- NDLS
- Stock Information
- Founded
- SABS 2014
- NDLS 1995
- Country
- SABS United States
- NDLS United States
- Employees
- SABS N/A
- NDLS N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- NDLS Restaurants
- Sector
- SABS Health Care
- NDLS Consumer Discretionary
- Exchange
- SABS Nasdaq
- NDLS Nasdaq
- Market Cap
- SABS 32.1M
- NDLS 34.3M
- IPO Year
- SABS N/A
- NDLS 2013
- Fundamental
- Price
- SABS $3.53
- NDLS $0.86
- Analyst Decision
- SABS Strong Buy
- NDLS Strong Buy
- Analyst Count
- SABS 5
- NDLS 2
- Target Price
- SABS $12.40
- NDLS $3.00
- AVG Volume (30 Days)
- SABS 69.6K
- NDLS 338.1K
- Earning Date
- SABS 11-06-2024
- NDLS 03-06-2025
- Dividend Yield
- SABS N/A
- NDLS N/A
- EPS Growth
- SABS N/A
- NDLS N/A
- EPS
- SABS N/A
- NDLS N/A
- Revenue
- SABS $1,512,723.00
- NDLS $495,817,000.00
- Revenue This Year
- SABS N/A
- NDLS N/A
- Revenue Next Year
- SABS N/A
- NDLS $0.14
- P/E Ratio
- SABS N/A
- NDLS N/A
- Revenue Growth
- SABS N/A
- NDLS N/A
- 52 Week Low
- SABS $2.16
- NDLS $0.55
- 52 Week High
- SABS $6.30
- NDLS $2.81
- Technical
- Relative Strength Index (RSI)
- SABS 46.39
- NDLS 61.95
- Support Level
- SABS $3.50
- NDLS $0.59
- Resistance Level
- SABS $4.35
- NDLS $0.75
- Average True Range (ATR)
- SABS 0.41
- NDLS 0.09
- MACD
- SABS -0.07
- NDLS 0.02
- Stochastic Oscillator
- SABS 19.22
- NDLS 96.61
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.